Blood Processing Devices and Consumables Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Devices, Consumables), By Usage (Red Blood Cells, Plasma, Platelets, Others), By Region and Competition, 2020-2030F

Market Overview

Global Blood Processing Devices and Consumables Market was valued at USD 45.26 Billion in 2024 and is expected to reach USD 61.60 Billion by 2030 with a CAGR of 5.47%. This market encompasses a wide range of products used for the collection, processing, storage, and transfusion of blood and its components, including blood bags, centrifuges, cell separators, reagents, filters, and other related consumables. The increasing prevalence of chronic diseases, rising surgical procedures, and a growing number of trauma cases have significantly contributed to the steady demand for blood and blood components, thereby boosting the need for advanced blood processing technologies.

In addition to technological innovation, the growing focus on voluntary blood donation and national blood safety programs in both developed and developing countries is creating a favorable environment for market expansion. Public and private healthcare organizations are investing in modernizing blood banks, expanding donor outreach, and integrating digital systems to track blood inventories and donor records. Despite its positive outlook, the market faces challenges such as the high cost of blood processing equipment and consumables, especially in low-income and resource-limited settings.

Key Market Drivers

Growth in Healthcare Industry

The growth of the global healthcare industry has emerged as a key driver of the Blood Processing Devices and Consumables Market. The global healthcare industry generates annual revenues exceeding USD 4 trillion. Among its most lucrative segments are pharmaceuticals and biotechnology, contributing nearly USD 850 billion, followed by medical technology and diagnostics, which account for over USD 400 billion in sales. As healthcare systems expand and modernize, particularly in response to rising patient volumes and the increasing prevalence of chronic and acute conditions, the demand for safe and efficient blood management practices has intensified. This has created a sustained need for advanced blood processing devices and high-quality consumables across hospitals, diagnostic laboratories, and blood banks.

Out of the approximately 313 million surgical procedures performed globally each year, only 6% take place in the world’s poorest countries, despite these regions being home to over one-third of the global population. The limited volume of surgical interventions in these areas is linked to elevated case-fatality rates for otherwise treatable conditions. The highest levels of unmet surgical need are observed in Eastern, Western, and Central sub-Saharan Africa, as well as in South Asia. The rising number of surgical procedures, trauma cases, and organ transplants globally is contributing to the heightened demand for reliable blood collection, separation, storage, and transfusion technologies. Moreover, advancements in therapeutic areas such as oncology, cardiology, and hematology where blood component analysis and transfusion play a critical role are further accelerating the adoption of sophisticated blood processing solutions.

Surge in Technological Advancements

The surge in technological advancements is a significant driver propelling the growth of the global blood processing devices and consumables market. Innovations in automation, precision diagnostics, and integrated blood management systems have revolutionized the way blood is collected, processed, and stored, leading to greater efficiency, accuracy, and safety in transfusion practices and therapeutic procedures. The E-blood bank is a comprehensive, integrated platform designed to streamline all blood bank operations from the collection of blood from both voluntary and replacement donors to the issuance of blood units to patients upon request. The system also features automated alert and acknowledgment mechanisms to facilitate communication between donors and blood bank personnel.

One of the most impactful developments has been the emergence of automated blood processing systems. These technologies enable the rapid separation of blood components such as red blood cells, plasma, and platelets with minimal manual intervention, significantly reducing the risk of contamination and human error. Advanced apheresis machines and centrifugation systems are now capable of processing large volumes of blood with greater consistency and enhanced yield, improving overall operational efficiency in blood banks and healthcare facilities.

Download Free Sample Report

Key Market Challenges

Shortage of Skilled Personnel

One of the critical challenges facing the global blood processing devices and consumables market is the shortage of skilled personnel required to operate and manage sophisticated blood processing systems. As healthcare systems increasingly adopt advanced technologies for blood collection, separation, testing, and storage, the demand for well-trained laboratory technicians, transfusion specialists, and biomedical engineers has grown significantly. However, the availability of such skilled professionals has not kept pace with market expansion, particularly in low- and middle-income countries.

Blood processing involves complex procedures that require precision, adherence to strict regulatory standards, and a thorough understanding of the equipment and protocols. Improper handling or lack of expertise can compromise the safety, quality, and efficiency of blood components, leading to wastage, increased risk of transfusion-related complications, and diminished patient outcomes. As a result, institutions lacking adequately trained staff may be hesitant to invest in new technologies or may underutilize existing systems.

Key Market Trends

Increasing Use of Blood Components in Therapeutics

The increasing use of blood components in therapeutics has emerged as a prominent trend in the global blood processing devices and consumables market. As clinical practices evolve to become more targeted and efficient, healthcare providers are increasingly shifting toward the use of specific blood components such as red blood cells, platelets, plasma, and cryoprecipitates rather than whole blood transfusions. This component-based therapy approach enhances treatment precision, minimizes transfusion-related risks, and ensures optimal utilization of donated blood.

This growing reliance on blood components is driving the demand for advanced blood processing technologies that enable accurate separation, preservation, and handling of individual components. For example, Reliance Life Sciences, the biotechnology arm of Mukesh Ambani’s Reliance Group has developed specialized plasma-derived proteins and blood products, and is establishing a world-class manufacturing facility for their production. The company has been motivated to set up this facility following the strong market response to its Factor VII product, which has emerged as a critical therapeutic solution for hemophilia patients suffering from Factor VII deficiency, a condition associated with severe blood clotting disorders. Devices such as centrifuges, apheresis systems, and automated cell separators are playing a critical role in supporting these therapeutic applications by ensuring high-quality yield, sterility, and regulatory compliance.

Segmental Insights

Product Insights

Based on Product, Devices have emerged as the fastest growing segment in the Global Blood Processing Devices and Consumables Market in 2024. This is primarily due to the increasing demand for automation, precision, and efficiency in blood handling and component separation. As healthcare systems worldwide prioritize safety, speed, and regulatory compliance, advanced devices offer solutions that significantly enhance the accuracy and scalability of blood processing workflows. Furthermore, technological advancements have led to the development of smart devices equipped with real-time monitoring, user-friendly interfaces, and integrated data management capabilities. These innovations allow for improved traceability, better inventory control, and compliance with increasingly stringent regulatory standards.

Usage Insights

Based on Usage, Red Blood Cells have emerged as the fastest growing segment in the Global Blood Processing Devices and Consumables Market during the forecast period. This is due to their critical role in treating a wide range of medical conditions and the increasing global demand for transfusion support. RBCs are essential for carrying oxygen throughout the body, making them indispensable in the management of severe blood loss, anemia, cancer-related treatments, surgeries, trauma care, and chronic illnesses such as kidney disease. The growing incidence of these medical conditions especially in aging populations and regions with limited access to preventive care has led to a surge in the need for reliable and efficient red blood cell processing and storage.

Download Free Sample Report

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Blood Processing Devices and Consumables Market in 2024. This is due to its advanced healthcare infrastructure, high adoption of innovative technologies, and strong regulatory framework. The region benefits from well-established systems for blood donation, storage, and transfusion, supported by a robust network of hospitals, blood banks, and diagnostic laboratories. In addition, the region demonstrates high per capita healthcare expenditure and a strong emphasis on patient safety, which accelerates the adoption of advanced and automated solutions for blood handling and processing. The implementation of stringent regulatory standards by agencies such as the U.S. Food and Drug Administration (FDA) ensures the widespread use of high-quality and compliant devices and consumables.

Recent Development

• In April 2024, BD (Becton, Dickinson, and Company) introduced the BD Vacutainer UltraTouch Push Button Blood Collection Set in India, aiming to reduce patient pain and discomfort while enhancing first-attempt success in blood collection. The device incorporates BD RightGauge technology, which allows for the use of a thinner needle, and BD PentaPoint Technology, collectively contributing to a marked reduction in insertion pain. Additionally, the set features BD’s Push Button Technology, which has been shown to reduce the risk of needlestick injuries by up to 88%, underscoring its commitment to both patient comfort and healthcare worker safety.
• In December 2024, BD (Becton, Dickinson and Company), a leading global medical technology firm, and Babson Diagnostics, a science-driven healthcare technology company, announced the expansion of their fingertip blood collection and testing solutions for deployment across U.S. health systems and major provider networks. These solutions are intended for use in urgent care centers, physician offices, and other ambulatory care settings. The advanced testing approach combines BD’s MiniDraw Capillary Blood Collection System with Babson’s BetterWay technologies, enabling accurate diagnostic results from as little as six drops of capillary blood collected from a patient’s fingertip. This minimally invasive alternative to traditional venipuncture allows trained healthcare personnel including those without prior phlebotomy experience to efficiently collect and prepare samples.
• In March 2025, Oneject unveiled the OneBag Blood Bag and the Oneject Hemodialysis Machine, representing a major milestone as the first domestically manufactured blood bag and hemodialysis machine in Indonesia with significant local content. Supported by Japanese technical expertise and fully automated production systems sourced from Germany, Japan, and Italy, Oneject’s advanced manufacturing facility is capable of producing up to 5 million blood bags and 1,500 hemodialysis machines annually. These innovations are strategically aligned with Indonesia’s healthcare needs, addressing the country’s annual demand of 5.5 million blood donations and 7.5 million hemodialysis treatments, while significantly reducing dependency on imports and strengthening supply chain resilience for healthcare providers.
• In February 2025, Tasso, Inc., a leading provider of patient-centric, clinical-grade blood collection solutions, unveiled its next-generation technology for dried blood spot (DBS) sample collection. This innovative system integrates the newly developed Tile-T20 dried whole blood cartridge with the Tasso Mini device, offering a more accurate and user-friendly solution for DBS sample collection, particularly in clinical trials and sports anti-doping programs. The advanced system delivers significant improvements over traditional DBS methods, streamlining and enhancing the efficiency of the clinical trial process. Tile-T20 is the first cartridge specifically engineered for use with patient-centric blood lancets, enabling the collection of four precise, volumetrically controlled samples suitable for quantitative analyses and drug concentration testing. The cartridge is fully compatible with Tasso’s FDA-cleared and CE Marked blood collection devices, including the Tasso Mini and Tasso+, which are designed to ensure a virtually painless experience for users.

Key Market Players

• Beckman Coulter, Inc.
• Haemonetics Corporation
• Maco Pharma International GmbH
• Poly Medicure Ltd.
• Immucor, Inc.
• Fresenius SE & Co KGaA
• Neomedic Limited
• Global Scientific Company
• Sigma Laborzentrifugen GmbH
• Terumo BCT, Inc

Report Scope

In this report, the Global Blood Processing Devices and Consumables Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Processing Devices and Consumables Market, By Product:

o   Devices

o   Consumables

• Blood Processing Devices and Consumables Market, By Usage:

o   Red Blood Cells

o   Plasma

o   Platelets

o   Others

• Blood Processing Devices and Consumables Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Processing Devices and Consumables Market.

Available Customizations:

Global Blood Processing Devices and Consumables Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Blood Processing Devices and Consumables Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]